Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction
Objectives. Low survival rate of mesenchymal stem cells (MSCs) severely limited the therapeutic efficacy of cell therapy in the treatment of myocardial infarction (MI). Bcl-xL genetic modification might enhance MSC survival after transplantation. Methods. Adult rat bone marrow MSCs were modified wit...
Saved in:
Main Authors: | Xiaodong Xue (Author), Yu Liu (Author), Jian Zhang (Author), Tao Liu (Author), Zhonglu Yang (Author), Huishan Wang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bcl-xL activity influences outcome of the mitotic arrest
by: M. Suleimenov, et al.
Published: (2022) -
MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022) -
Bcl-xL DNAzymes promote radiosensitivity and chemosensitivity in colorectal cancer cells via enhancing apoptosis
by: Zhen Yu, et al.
Published: (2022) -
BCL-xL is correlated with disease severity in neonatal infants with early sepsis
by: Wu Wenshen, et al.
Published: (2021) -
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
by: Mike-Andrew Westhoff, et al.
Published: (2022)